Masters in Business

Todd Harrison Discusses Biopharmaceutical Investments

Bloomberg Opinion columnist Barry Ritholtz interviews Todd Harrison, a founding partner and chief investment officer at the hedge fund CB1 Capital, which focuses on cannabinoid-based solutions and biopharmaceutical applications and therapies. Prior to his work with CB1 Capital, Harrison spent almost three decades on Wall Street managing risk and…